Abstract
In the published article, there was an error in the Funding statement. The current statement is “This work was supported by operating funds to AE from the Canadian Institutes of Health Research (FDN-148399) and generous start-up funds from Boston University.” The correct Funding statement appears below. “This work was supported by operating funds to AE from the Canadian Institutes of Health Research (FDN-148399) and generous start-up funds from Boston University. This work was also supported by funds to VC from the National Heart Lung and Blood Institute (1R01HL166608).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
| Original language | English |
|---|---|
| Article number | 1376058 |
| Journal | Frontiers in Pharmacology |
| Volume | 15 |
| DOIs |
|
| State | Published - 2024 |
Keywords
- ESKD
- integrated omics
- metabolomics
- nLC-MS/MS
- proteomics
Fingerprint
Dive into the research topics of 'Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease(Front. Pharmacol., (2023), 14, (1243505), 10.3389/fphar.2023.1243505)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver